Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
A phase 2 trial of Dexamethasone, Vincristine, Rituximab, Clofarabine, Cyclophosphamide, Etoposide, Aldesleukin, Asparaginase, Methotrexate, Mercaptopurine, Cytarabine, Mitoxantrone, Teniposide and Vinblastine in Acute lymphoblastic leukaemia, run by St. Jude Children's Research Hospital, completed.
Overview
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma is a phase 2 interventional study registered as NCT01700946 by St. Jude Children's Research Hospital, with 80 participants recorded, started 2013-04-15 and reaching its primary completion in 2021-07-24. Interventions recorded: dexamethasone, vincristine sulfate, rituximab, clofarabine, cyclophosphamide, etoposide, aldesleukin, pegaspargase, methotrexate, mercaptopurine, cytarabine, mitoxantrone, teniposide, vinblastine, natural killer cell infusion, laboratory biomarker analysis, therapeutic hydrocortisone, allogeneic hematopoietic stem cell transplantation, CliniMACS. Conditions recorded: Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma.
Linked to the drug Teniposide because the registry names it among its interventions and Acute lymphoblastic leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Shares Clofarabine, Mercaptopurine, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Mercaptopurine, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Cytarabine, Methotrexate and the tag pipeline.
- TrialInotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Shares Mercaptopurine, Cytarabine, Methotrexate, Dexamethasone and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Mitoxantrone, Cytarabine, Dexamethasone, Vincristine and the tag pipeline.
- TrialInternational Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Shares Mercaptopurine, Cytarabine, Methotrexate, Dexamethasone and the tag pipeline.
- TrialRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Shares Cytarabine, Methotrexate, Vincristine, Etoposide and the tag pipeline.
- TrialCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Shares Mitoxantrone, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Cytarabine, Methotrexate and the tag pipeline.
- TrialTreatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Shares Cytarabine, Methotrexate, Dexamethasone, Vincristine and the tag pipeline.